EUDA Health Holdings Limited's operating expenses surged in Q2 2023 due to several factors:
- Non-compliance with Nasdaq Listing Rules: EUDA Health received a delinquency notification letter from Nasdaq on May 19, 2023, due to its failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 202312. This non-compliance led to additional expenses likely related to remediation efforts and maintaining compliance with Nasdaq listing requirements.
- Additional Time to Regain Compliance: Nasdaq granted EUDA Health up to September 27, 2023, to file the Form 10-Q and the Form 10-K to regain compliance12. The company's expenses increased as it worked to submit a plan to regain compliance and then filed the required reports within the extended timeframe.
In summary, the surge in operating expenses in Q2 2023 was primarily due to the costs associated with addressing Nasdaq's delinquency concerns and the extended timeframe to regain compliance with listing rules.